Cahill Brian Joseph

CIK 0001831591

Chief Financial Officer

Filings

Latest Feb 29, 2024

Issuers covered

Showing

13 of 13

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Cahill Brian Joseph. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Cahill Brian Joseph has filed

Ticker	Issuer	Filings	Last filed
EGRX	Eagle Pharmaceuticals, Inc.	13	Feb 29, 2024

13 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 29, 2024	EGRXEagle Pharmaceuticals, Inc.	FTax	1,589	$6.44	$10,233
Feb 6, 2024	EGRXEagle Pharmaceuticals, Inc.	FTax	934	$5.85	$5,464
Jan 9, 2024	EGRXEagle Pharmaceuticals, Inc.	FTax	735	$5.13	$3,771
Dec 20, 2023	EGRXEagle Pharmaceuticals, Inc.	FTax	452	$4.76	$2,152
Mar 2, 2023	EGRXEagle Pharmaceuticals, Inc.	FTax	718	$28.00	$20,104
Feb 6, 2023	EGRXEagle Pharmaceuticals, Inc.	FTax	785	$34.09	$26,761
Jan 31, 2023	EGRXEagle Pharmaceuticals, Inc.	FTax	601	$33.21	$19,959
Jan 9, 2023	EGRXEagle Pharmaceuticals, Inc.	FTax	734	$29.26	$21,477
Mar 2, 2022	EGRXEagle Pharmaceuticals, Inc.	AGrant	8,000	$0.00	$0
Feb 4, 2022	EGRXEagle Pharmaceuticals, Inc.	FTax	805	$45.03	$36,249
Feb 1, 2022	EGRXEagle Pharmaceuticals, Inc.	FTax	626	$45.94	$28,758
Jan 11, 2022	EGRXEagle Pharmaceuticals, Inc.	FTax	263	$50.63	$13,316
Jan 7, 2022	EGRXEagle Pharmaceuticals, Inc.	FTax	738	$50.69	$37,409

Showing 1-13 of 13

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.